- Dimensione: azienda di medie o grandi dimensioni
- Entrate: 3-30M EUR
- Posizione dell'obiettivo: Europa
- Reason for acquisition: The company decided to sell its Phase 2 and Phase 3 capabilities and is now looking to grow further into phase I CRO activity.
- #CFIE PHB038
Overview of this buyer for Phase I clinical trials CRO
The buyer is a contract research organization that has a focus on Phase I clinical trials and would like to acquire company with the same or similar characteristics.
Profile (strategy) of this buyer for Phase I clinical trials CRO
The buyer is one of leading European contract research organization and pharmaceutical company which specializes on early stage drug development for the life science industry.
It is a company that is on the market for more than 35 years and during the last years, is very active in acquisitions.
The company also performs drug trials for international pharmaceutical companies, biotech and generic manufacturers.
Other services included in the company’s portfolio: pharmaceutical services, clinical services, non- clinical services and laboratory services.
The company is financially very strong and is capable to bid a very good offer if attractive company appears.
Contattateci per avere informazioni dettagliate su questa azienda farmaceutica.
Attività e prodotti dell'azienda target
The buyer is looking for a well-established, mid-size company with a strong financial record and team of experts around. Preferred target is a contract research company which specializes on early stage drug development for the life science industry. Desired company regularly invents suitable dose of a new drug with the fewest side effects. Than is capable of drug testing on the patients and makes the drug ready to launch on the market.
Highlights of this buyer for Phase I clinical trials CRO in Europe
- L'acquirente è un'organizzazione di ricerca a contratto e un'azienda farmaceutica leader, specializzata nello sviluppo di farmaci in fase iniziale per l'industria delle scienze della vita.
- Is looking for a financially stable company with a potential and yearly revenue between Has revenue 3-30m
- Preferred company would perform drug trials for international pharmaceutical companies, biotech and generic manufacturers.
- Other services that the buyer is interested are: pharmaceutical services, clinical services, non- clinical services and laboratory services
Information on this buyer for a Phase I clinical trials CRO
Feel free to contact us for more information regarding this generic drugs company wanted in Europe, or if you know possible interested or suitable parties. For more buyers of pharmaceutical companies please visit the section aziende farmaceutiche cercasi. Per le aziende farmaceutiche in vendita visita la sezione aziende farmaceutiche in vendita.
Ulteriori informazioni sulla Phase I clinical trials CRO company wanted in Europe
Non esiti a contattarci per saperne di più su questa Phase I clinical trials CRO company wanted in Europe. Per ulteriori aziende farmaceutiche in vendita, visitate la sezione aziende farmaceutiche in vendita. Per gli altri acquirenti di prodotti farmaceutici, visitate la sezione cercasi aziende farmaceutiche. Se invece le interessano le aziende farmaceutiche in vendita, visiti il sito aziende farmaceutiche in vendita sezione. Per gli acquirenti di prodotti farmaceutici, visiti la sezione cercasi aziende farmaceutiche.